Pediatric tuberculosis (TB) often presents atypically, with nonspecific symptoms such as failure to thrive, persistent cough, or lymphadenopathy. The diagnosis is challenging in children. However, recent advances like GeneXpert MTB/RIF and interferon-gamma release assays (IGRAs) have improved diagnostic yield, especially in high-risk populations. The WHO 2023 guidelines now advocate for symptom-based screening in endemic regions and expanded use of isoniazid preventive therapy (IPT).
Can you navigate these new diagnostic challenges? References : International Journal of Infectious Diseases and BMC Infectious Diseases ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about the information's suitability, reliability, or adequacy, including data visualization elements…
